Fred C Tenover
Overview
Explore the profile of Fred C Tenover including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
8094
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tenover F, Tickler I
Antibiotics (Basel)
. 2024 Sep;
13(9).
PMID: 39335038
We analyzed the whole genome sequences (WGS) and antibiograms of 35 isolates, including and , and the recently described , , , and species. Isolates were obtained from human blood...
2.
Barlow M, Tenover F
JAC Antimicrob Resist
. 2024 Jan;
6(1):dlad150.
PMID: 38213313
Objectives: We investigated the amino acid substitutions in the GES family of ESBLs that were most likely to be involved in the evolution of carbapenemase activity. Methods: To identify the...
3.
Kawa D, Tickler I, Tenover F, Shettima S
Trop Med Infect Dis
. 2023 Nov;
8(11).
PMID: 37999619
Infections due to antimicrobial resistant gram-negative bacteria cause significant morbidity and mortality in sub-Saharan Africa. To elucidate the molecular epidemiology of antimicrobial resistance in gram-negative bacteria, we characterized beta-lactam and...
4.
Tops S, Schapendonk C, Coolen J, Tenover F, Tickler I, Melchers W, et al.
Microbiol Spectr
. 2023 Nov;
11(6):e0311623.
PMID: 37962375
Early identification of complicated urinary tract infections caused by ESBL-producing Enterobacterales has the potential to limit the use of carbapenems to those patients without alternative antibiotic options and avoid the...
5.
Tickler I, Kawa D, Obradovich A, Fang F, Tenover F, The Healthcare Associated Infections Consortium
Antibiotics (Basel)
. 2023 Sep;
12(9).
PMID: 37760683
A total of 199 Gram-negative bacterial isolates from urinary tract infections and 162 from bloodstream infections were collected from 12 healthcare systems throughout the United States between May 2021 and...
6.
Zhou W, Shen L, Shi J, Gao X, Yang J, Fu S, et al.
Infection
. 2023 Aug;
52(2):403-412.
PMID: 37651077
Purpose: Donor-derived infection (DDI) has become an important factor affecting the prognosis of lung transplantation patients. The risks versus benefits of using donor organs infected with multidrug-resistant organisms (MDRO), especially...
7.
Medugu N, Tickler I, Duru C, Egah R, James A, Odili V, et al.
Sci Rep
. 2023 Jun;
13(1):10306.
PMID: 37365355
Infections caused by multi-drug resistant Enterobacterales (MDR-E) are difficult to treat and cause significant mortality, especially in developing countries. This study characterized the phenotypic and genotypic profiles of 49 randomly...
8.
Tenover F, Goff D
Open Forum Infect Dis
. 2023 Apr;
10(4):ofad176.
PMID: 37089778
Colonization with multidrug-resistant organisms (MDROs) is a risk factor for subsequent infection. Surveillance for MDROs, including methicillin-resistant , vancomycin-resistant enterococci, extended-spectrum beta-lactamase-producing Enterobacterales, and carbapenemase-producing organisms, is commonly conducted in...
9.
Brecher S, Tickler I, Tenover F
Ann Clin Microbiol Antimicrob
. 2023 Apr;
22(1):24.
PMID: 37055768
Background: Carbapenemase-producing gram-negative organisms continue to be a significant healthcare concern and a therapeutic challenge. Members of the genus Citrobacter have emerged as increasingly multidrug resistant and versatile healthcare-associated pathogens....
10.
Gill C, Rajkotia P, Roberts A, Tenover F, Nicolau D
Emerg Microbes Infect
. 2023 Feb;
12(1):2179344.
PMID: 36786132
Molecular carbapenem-resistance testing, such as for the presence of carbapenemases genes, is commonly implemented for the detection of carbapenemase-producing Enterobacterales. Carbapenemase-producing is also associated with significant morbidity and mortality, although;...